Uploaded November 2024 | Updated September 2026, 2 weeks ago
A new wave of long-acting HIV preventatives has the potential to transform the fight against HIV/AIDS. By providing strong protection without the stigma or inconvenience of daily pills, lenacapavir—an injection taken just twice a year—could significantly reduce new infections, especially in underserved areas. Learn more about the latest advances in HIV prevention, and other promising drugs in the development pipeline, at gatesnot.es/4eIIqKr.
A new wave of long-acting HIV preventatives has the potential to transform the fight against HIV/AIDS. By providing strong protection without the stigma or inconvenience of daily pills, lenacapavir—an injection taken just twice a year—could significantly reduce new infections, especially in underserved areas. Learn more about the latest advances in HIV prevention, and other promising drugs in the development pipeline, at gatesnot.es/4eIIqKr.










